✦ LIBER ✦

Improving first-line therapy of advanced ovarian cancer – the AGO Ovarian Cancer Study Group perspective

✍ Scribed by A. Du Bois; J. Pfisterer; W. Meier; U. Wagner; for the ago Ovarian Cancer Study Group; Germany

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Future options for first-line therapy of

✍ A. Du Bois; J Pfisterer 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 323 KB

First-line treatment for advanced ovaria

✍ Sandercock, J; Parmar, M K B; Torri, V; Qian, W 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 131 KB

Neuroprotection with amifostine in the f

✍ F. Hilpert; A. Stähle; O. Tomé; A. Burges; D. Rossner; K. Späthe; V. Heilmann; B 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 185 KB

A phase II study of weekly carboplatin a

✍ Sandro Pignata; Enrico Breda; Giovanni Scambia; Carmela Pisano; Vittorina Zagone 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 208 KB

Phase II study of carboplatin followed b

✍ M. FRIEDLANDER; M. BUCK; D. WYLD; M. FINDLAY; B. FITZHARRIS; P. DE SOUZA; T. DAV 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

A multicenter phase II study of cisplati

✍ Véronique Diéras; JeanPaul Guastalla; JeanMarc Ferrero; Hervé Curé; Béatrice Web 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 208 KB